We gathered various heterogeneous datasets from high-throughput experimental techniques such as DNase I hypersensitive sites sequencing (DNase-seq) for prioritization of candidate causal variants, ChIP-seq for TF binding evidence, and chromatin interaction analysis with paired-end tag sequencing (ChIA-PET) and RNA-seq for target gene prioritization in breast cancer samples or cell lines (section “Materials and Methods”; Supplementary Table 1). This evidence concerns the gene TF and breast carcinoma.